Purchase Order 75N98026P01396

<p>The National Cancer Institute awarded a purchase order to Cytek Biosciences, Inc. for $9,482.00 on January 9, 2018, with completion by January 14, 2019. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not specify the equipment or services procured.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $10,482.50 firm fixed price purchase order to Cytek Biosciences, Inc. Cytek Biosciences Division for SERVICE AGREEMENT. The place of performance will be in Bethesda, Maryland. The period of performance is from November 1, 2023 through January 31, 2024. As the National Cancer Institute conducts research into cancer causes, prevention, diagnosis, and treatment, this purchase order is...

<p>The National Cancer Institute awarded a purchase order to Cytek Biosciences, Inc. valued at $8,983.00 on March 23, 2018, for completion by March 31, 2019. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase covers flow cytometry equipment or related scientific instrumentation and technical support services.</p>

<p>The National Cancer Institute awarded a purchase order to Cytek Biosciences, Inc. for $190,800 on September 19, 2019, to de-obligate funds from FY2019 expiring lines in accordance with NIH OALM communication. Performance will take place in Fremont, California. The order is firm fixed price with an ultimate completion date of December 20, 2019. No set-aside was applied. The solicitation was posted August 30, 2019, with a closing date of September 6, 2019.</p>

The National Cancer Institute awarded a purchase order to Cytek Biosciences, Inc. for maintenance services on a government-owned Cytek Amnis ImageStream ISX MarkII imaging flow cytometry cell analyzer, with a ceiling value of $210,000 and an award date of April 1, 2024. Place of performance is Bethesda, Maryland. The purchase order covers preventative and emergency maintenance services for the analyzer, which includes four lasers, two cameras, autosampler, and computer workstation in support...

<p>The National Cancer Institute, National Institutes of Health, awarded a purchase order to Cytek Biosciences, Inc. for $35,392.00 on August 15, 2026, with completion by August 14, 2027. No set-aside was used. Performance occurs in Fremont, California. The order is firm fixed price for advanced flow cytometry systems and related scientific instrumentation supporting research conducted by the Lymphoid Malignancies Branch at the Center for Cancer Research.</p>

The National Cancer Institute (NCI) awarded a firm fixed-price purchase order to Cytek Biosciences, Inc. for maintenance services supporting six Cytek Aurora flow cytometry devices at the NCI's Center for Cancer Research (CCR) in Bethesda, Maryland. The equipment fleet consists of four Aurora 5-laser systems with automated loaders, one Aurora 4-laser system with loader, and one Aurora cell sorter. The contract, valued at $676,499.66, was awarded on April 1, 2023, with an ultimate completion date...

This is a firm fixed-price purchase order for $73,781.00 awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Cytek Biosciences, Inc. for maintenance services on a government-owned Cytek Aurora CS Spectral Cell Sorter. The base period of performance is February 1, 2024 through January 31, 2025, with four optional one-year extensions. Services include two planned preventative maintenance visits annually, unlimited remote technical support,...

<p>The National Cancer Institute issued a $10,013 delivery order to Beckman Coulter, Inc. on March 25, 2019, for instrument maintenance services with a completion date of March 31, 2020. Place of performance is Bethesda, MD. The order is priced firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. on June 8, 2026, for maintenance services on Novocyte 3000 and NovoSampler Pro equipment, valued at $17,520.00, with a completion date of June 7, 2027. Work is performed in Bethesda, Maryland. The contract is firm fixed price with no set-aside designation.</p>